Izvarino Pharma

Izvarino Pharma is a prominent Russian pharmaceutical company dedicated to the development and production of high-quality medicinal products. Founded in 2007, the company operates a modern, GMP-compliant manufacturing facility located in the Vnukovskoye settlement of Moscow. Its primary business focus includes the therapeutic areas of transplantology, cardiology, gynecology, and endocrinology, where it provides both generic and innovative solutions. Izvarino Pharma is recognized for its role in the Russian import substitution program, localizing the production of critical drugs such as immunosuppressants and cardiovascular agents. The company maintains a strong emphasis on research and development to expand its portfolio of solid oral dosage forms. Through strategic partnerships and a robust distribution network, Izvarino Pharma ensures the availability of essential treatments across the Russian Federation and CIS regions.